Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour‐related pain

BACKGROUND: A recent randomized‐withdrawal, active‐ and placebo‐controlled, double‐blind phase 3 study showed that tapentadol prolonged release (PR) was effective and well tolerated for managing moderate to severe, chronic malignant tumour‐related pain in patients who were opioid naive or dissatisfi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Pain
Main Authors: Kress, H.G., Koch, E.D., Kosturski, H., Steup, A., Karcher, K., Dogan, C., Etropolski, M., Eerdekens, M.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2016
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5071659/
https://ncbi.nlm.nih.gov/pubmed/27062079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejp.875
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker